Latest filing published 04 Mar 2014 for Mirati Therapeutics, Inc., €3,119.
Insider track record
No signal scores available.
Martin Godbout: trading record in brief
Martin Godbout is a declared insider of Mirati Therapeutics, Inc., with filings sourced from SEC (Form 4). We count 2 filings; the first trade dates from 16 December 2013 and the latest from 4 March 2014.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
On 4 March 2014 came the latest disclosure, an option exercise for €3,119 in Mirati Therapeutics, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Martin Godbout
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 300 shares@ US$14.28Common StockSEC:0001209191-14-016985:0
- 200 shares@ US$9.50Common StockSEC:0001209191-13-057186:0
2 of 2 declarations
